SEC Form D private-offering filing

Atommap Corp

Name: Atommap Corp - new SEC Form D private-offering filing, New York, NY
Published: 2026-03-20

A new SEC Form D private-offering notice from New York, NY, a $59,630,328 filer-stated offering target in Biotech. The source filing is one click away.

Atommap Corp site↗ Verified via SEC Form D

Computational drug discovery company, rebranded from Atommap to Fathom Therapeutics, using physics based and AI augmented molecular simulation to design therapeutic small molecules.

Filed 2026-03-20Filed to raise $59,630,328First money in 2026-03-06Raised so far $31,130,335HQ (as filed) New York, NYSector Biotech ✓Stage (inferred) GrowthCall status Call-ready

Source linked the Form D on EDGAR↗Website verified fathomtx.com↗Named in the filing 2 executives & directors

Open this row on the live feed →More new filings in New York →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.